Grifols | GRFS - Le Bénéfice D'Exploitation

Prix De L'Action
8.21
Variation Quotidienne
0.16 1.99%
Mensuellement
2.24%
Annuel
21.45%
Q2 Prévisions
7.99




Le Bénéfice D'Exploitation Changement Date
Alaunos Therapeutics USD -1.19M 148K 2025-09
Arca Biopharma USD -34.43M 326K 2025-12
aTyr Pharma USD 24.47M 51.21M 2025-12
Bio Path USD -488K 4.07M 2025-09
Brainstorm Cell Therapeutics USD -2.24M 197K 2025-12
Capricor Therapeutics USD -29.16M 2.87M 2025-12
Cara Therapeutics USD -5.94M 3.55M 2025-09
Esperion Therapeutics USD 85.23M 95.19M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Grifols EUR 320.55M 91.01M 2025-12
Immunic USD -25.73M 2.91M 2024-09
Infinity Pharmaceuticals USD -10.12M 1.39M 2023-06
Minerva Neurosciences USD -21.85M 17.48M 2024-12
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Sangamo BioSciences USD -33.51M 12.77M 2024-06
TherapeuticsMD USD -1.18M 40K 2024-06